The Global Antibacterial Drugs Market's Key Trends
To expand their product range, the market's key players are focusing on the approval and release of new goods. For example, in September 2019, Kyorin Pharmaceutical Co., Ltd. received approval from Japan's Ministry of Health, Labor, and Welfare to commercialise Lasvic Tablets 75mg, an oral quinolone antibacterial drug used to treat respiratory and ENT infections.
The key competitors in the Antibacterial Drugs Market are also focusing on the development of new antibacterial drugs. Iterum Therapeutics plc, for example, presented data on sulopenem, a new oral and IV penem antibiotic, at IDWeek 2018 in San Francisco, California, in October 2018.
Source Link @ https://www.coherentmarketinsights.com/press-release/antibacterial-drugs-market-to-surpass-us-497-billion-by-2026-134
Source Link @ https://www.coherentmarketinsights.com/market-insight/antibacterial-drugs-market-177
